Wells Fargo Is Bullish on Inspire Medical Systems, Inc. (INSP) Despite Short-Term Reimbursement Concerns

Company Overview - Inspire Medical Systems, Inc. is a U.S. medical technology company focused on developing and commercializing minimally invasive neurostimulation solutions for patients with moderate to severe obstructive sleep apnea [3] Financial Performance - Inspire Medical Systems projected 2026 revenue between $1.003 billion and $1.013 billion, with Q4 revenue estimated at $268.9 million to $269.1 million, both exceeding consensus expectations [2] Analyst Ratings - Wells Fargo lowered its price target on Inspire Medical Systems to $145 from $160 while maintaining an Overweight rating, indicating confidence in the company's ability to manage reimbursement issues despite potential short-term challenges [1]